Nanoelectrode Arrays for Protease Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting proteases, such as legumain, cathepsin B, and MMP-7, are limited by requiring large sample amounts, centralized lab setups, and the inability to analyze multiple proteases simultaneously, making early cancer diagnosis and treatment monitoring inefficient.
Innovation Solution
Development of nanoelectrode arrays (NEAs) with vertically aligned carbon nanofibers (VACNFs) that attach specific peptides, which are cleaved by target enzymes, causing a change in redox signal measurable by AC voltammetry, allowing for sensitive and rapid detection of multiple proteases in a point-of-care setting.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional fluorogenic proteolytic beacon or ELISA methods are used for protease detection, then detection can be performed, but large amounts of sample and reagent are necessary
Solution Approach 1:
The patent utilizes nanoelectrode arrays with high surface-area-to-volume ratio that function similarly to porous structures, enabling enhanced detection sensitivity with minimal sample volume. The nanoscale electrodes provide numerous active sites for enzyme-substrate interaction, allowing detection of proteases at very low concentrations without requiring large sample amounts.
Solution Approach 2:
The invention changes the detection parameters from conventional fluorogenic or immunological methods to electrochemical detection using nanoelectrodes. This parameter change enables detection with much smaller sample volumes while maintaining or improving sensitivity, as the electrochemical signal amplification at nanoscale electrodes provides high detection capability with minimal material input.
2Ease of operation
If conventional fluorogenic proteolytic beacon or ELISA methods are used for protease detection, then detection can be performed, but a workstation in a centralized lab is required
Solution Approach 1:
The patent extracts the core detection function from complex centralized laboratory workstations and implements it in a simplified, portable nanoelectrode array format. By isolating the essential detection mechanism (electrochemical sensing at nanoscale electrodes) from the bulky laboratory equipment, the system enables point-of-care testing without requiring full laboratory workstations.
Solution Approach 2:
The invention replaces complex mechanical and optical systems (fluorogenic beacons, ELISA plate readers) with an electrochemical sensing system based on nanoelectrode arrays. This substitution simplifies the device architecture, reduces the need for complex workstations, and enables more accessible point-of-care operation while maintaining detection capability.
3Adaptability or versatility
If conventional methods are used for protease detection, then one protease can be analyzed, but only one protease can be analyzed in each measurement
Solution Approach 1:
The patent segments the detection surface into multiple nanoelectrode sites, each functionalized with different peptide substrates specific to different proteases. This segmentation enables simultaneous detection of multiple proteases in a single measurement, as each nanoelectrode array region can independently detect a specific protease target, thereby increasing both versatility and throughput.
Solution Approach 2:
The nanoelectrode array platform provides universal detection capability for multiple proteases by using a common electrochemical detection method applied to different peptide-substrate-functionalized electrodes. This multi-functional approach allows a single device to detect various proteases (legumain, cathepsin B, MMP-7, etc.) simultaneously, enhancing both adaptability and productivity without requiring separate assays for each protease.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The NEAs provide high sensitivity, enabling the detection of nanomolar concentrations of proteases with reduced false positives and non-specific binding, facilitating early cancer screening and treatment monitoring with improved specificity and speed.
Implementation Method 1
A redox moiety, such as ferrocene (Fc), can be linked at the distal end of the CNFs. Upon being exposed to a biological sample containing one or more target enzymes, the change in redox signal of the redox moiety due to cleavage of the peptides can be measured using AC voltammetry
Implementation Method 2
the change in redox signal of the redox moiety due to cleavage of the peptides can be measured using AC voltammetry (ACV)
Data Source
AI summary
An electrochemical method for measuring the activity of enzymes using nanoelectrode arrays fabricated with vertically aligned carbon nanofibers. Short peptide substrates specific to disease-related enzymes are covalently attached to the exposed nanofiber tips. A redox moiety, such as ferrocene, can be linked at the distal end of the nanofibers. Contact of the arrays with a biological sample containing one or more target enzymes results in cleavage of the peptides and changes the redox signal of the redox moiety indicating the presence of the target enzymes.